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Epidermal morphogenesis begins with the commitment of the single-layered surface ectoderm to initiate a stratification program, a process that
requires the expression of the transcription factor TAp63a. To determine the molecular mechanism by which TAp63a induces genes associated
with the commitment to stratification, such as K14, we have used a combination of in vitro and in vivo approaches. Our initial gene expression
profiling studies suggested that TAp63a could regulate one or more AP-2 genes, which have been implicated in development and maintenance of
the epidermis. We now demonstrate that TAp63a directly induces AP-2g expression in embryonic epidermis, when commitment to stratification
occurs. Furthermore, we show that, in the absence of AP-2g, TAp63a fails to induce K14 expression in vitro. Our data identify AP-2g as the first
in vivo target gene of TAp63a, and provide novel insights into the molecular mechanisms associated with early events in epidermal
morphogenesis.
D 2005 Elsevier Inc. All rights reserved.Keywords: p63; AP-2; Epidermal development; StratificationIntroduction
During embryogenesis, the epidermis develops from a
single-layered epithelium into a stratified epithelium which
provides the organism with a protective barrier. A gene that is
essential for epidermal morphogenesis is the transcription
factor p63, as demonstrated by the block in epidermal
development displayed by p63/ mice (Koster et al., 2004;
Mills et al., 1999; Yang et al., 1999). The p63 gene contains
two promoters, giving rise to six transcripts that contain (TA)
or lack (DN) a transactivation domain (Yang et al., 1998). All
p63 isoforms contain an identical DNA binding domain which
is homologous to the p53 DNA binding domain, and p63
transactivates gene expression by binding to degenerate p53
response elements (Bian and Sun, 1997; Zeng et al., 1998). We
recently demonstrated that TAp63 isoforms are the first p630012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.10.041
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E-mail address: roopd@bcm.tmc.edu (D.R. Roop).isoforms expressed in the single-layered surface ectoderm and
that they are expressed prior to the commitment to stratifica-
tion, the first event associated with epidermal morphogenesis
(Koster et al., 2004). Furthermore, we found that ectopic
expression of a TAp63 isoform, TAp63a, could initiate an
epithelial stratification program in epithelia that normally
remain single-layered, demonstrating its role as a master
molecular switch (Koster et al., 2004).
Although several p63 target genes have been described
(Barbieri et al., 2005; Dohn et al., 2001; Gressner et al., 2005;
Ihrie et al., 2005; Kim et al., 2004; Kurata et al., 2004; Nishi et
al., 2001; Osada et al., 2005a,b; Sasaki et al., 2001, 2005;
Westfall et al., 2003), in vivo target genes of TAp63 isoforms
that function during early epidermal morphogenesis have not
yet been identified. One gene which is regulated by TAp63a
and that is induced upon the commitment to stratification is
K14 (Byrne et al., 1994; Koster et al., 2004). It is possible that
TAp63a directly induces K14 expression by interacting with
the K14 promoter. Alternatively, TAp63a may regulate the
expression of another gene that is ultimately responsible for the
induction of K14 expression. Candidate genes that could89 (2006) 253 – 261
www.e
M.I. Koster et al. / Developmental Biology 289 (2006) 253–261254regulate this process are members of the AP-2 gene family. The
mammalian AP-2 gene family comprises 5 transcription
factors, AP-2a-(, that are critical for embryonic development
(Auman et al., 2002; Cheng et al., 2002; Feng and Williams,
2003; Hilger-Eversheim et al., 2000; Panteleyev et al., 2003;
Tummala et al., 2003; Wang et al., 2004; Werling and Schorle,
2002; Zhao et al., 2001, 2003). Members of the AP-2 gene
family have been implicated in development and differentiation
of the epidermis in several species, including zebrafish,
Xenopus, mice, and humans (Kaufman et al., 2002; Knight et
al., 2005; Leask et al., 1991; Luo et al., 2002; Sinha et al.,
2000). Furthermore, functional AP-2 binding sites have been
identified in the promoters of several keratinocyte-specific
genes including K5 and K14 (Kaufman et al., 2002; Leask et
al., 1991; Sinha et al., 2000). A role for AP-2 genes in the
initiation of K5 and K14 expression during epidermal
development was suggested by the finding that AP-2 expres-
sion precedes K5 and K14 expression in the embryonic
epidermis (Byrne et al., 1994; Chazaud et al., 1996). However,
AP-2 expression is not sufficient to regulate epidermal-specific
K14 expression in mature epidermis in vivo and it has been
suggested that other transcription factors act cooperatively with
AP-2 to regulate K14 expression in the epidermis (Sinha et al.,
2000). Since these studies were performed by manipulating
AP-2 binding sites in the K5 and K14 promoter regions, theFig. 1. AP-2g is a target gene of TAp63a. Primary surface epithelial cells were isola
RT-PCR analysis demonstrated that AP-2g is not expressed in p63/ epithelial cells
2g expression in p63/ epithelial cells is not detectable by Real-time RT-PCR. Furt
upon induction of TAp63a expression in primary keratinocytes (C). This increase
which DNp63 expression levels are reduced ¨2-fold, suggesting that DNp63a neg
induce AP-2g expression in single-layered epithelia, where DNp63 is not expressed
gene-switch mice (SP-C.Glp65/TAp63a). In this context, AP-2g, but not AP-2a an
TAp63a can induce AP-2g in vivo in single-layered epithelia, such as the surfaceAP-2 isoform involved in the regulation of these genes is not
known. Moreover, a direct link between AP-2 and induction of
these early markers of commitment to stratification in
embryonic epidermis has yet to be demonstrated. We now
demonstrate that TAp63a directly induces AP-2g expression in
embryonic epidermis, when commitment to stratification
occurs. Furthermore, we demonstrate that, in the absence of
AP-2g, TAp63a fails to induce K14 expression in vitro,
suggesting that AP-2g is required for the initiation of K14
expression during epidermal morphogenesis. These data
identify AP-2g as the first in vivo target gene of TAp63a,
and provide novel insights into the molecular mechanisms
associated with early events in epidermal morphogenesis.
Results and discussion
To understand the molecular mechanism by which TAp63a
initiates epithelial stratification, we initially performed gene
expression profiling studies using Affymetrix microarrays.
Since in p63/ mice, the surface ectoderm fails to commit to
stratification, we compared gene expression profiles of p63/
and wild type E18.5 skin. Analysis of the microarray data
demonstrated that the expression of several genes that are
believed to be essential for the initial development and continued
maintenance of a basal layer, such as members of the SPted from E18.5 p63/ and wild type embryos. RT-PCR analysis and Real-time
, suggesting that AP-2g is a downstream target gene of TAp63a (A, B). (*) AP-
hermore, expression levels of AP-2g, but not AP-2a and AP-2h, were increased
was more pronounced when TAp63a was induced in a p63+/ background, in
atively regulates AP-2g expression (C). To determine the ability of TAp63a to
, we ectopically expressed TAp63a in single-layered lung epithelia using lung
d AP-2h, expression levels were induced at higher levels, demonstrating that
ectoderm (D).
Fig. 2. TAp63a regulates the AP-2g promoter. To identify potential regulatory
elements in the AP-2g promoter, a cross-species comparison between mouse
and human AP-2g promoter sequences was performed using the VISTA
genome server (A) (Mayor et al., 2000). Areas colored pink indicate conserved
sequences (70% conservation over a 100 bp region). Reporter gene assays
using promoter fragments shown in (A) demonstrated that the conserved region
designated ‘‘AP-2g conserved 1’’ can be regulated by TAp63a (B).
Furthermore, increasing amounts of DNp63a inhibited transactivation of
‘‘AP-2g conserved 1’’ by TAp63a in a dose-dependent manner, demonstrating
that DNp63a has a dominant-negative effect towards TAp63a (C).
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et al., 1997) was decreased in p63/ skin. AP-2 genes are
expressed prior to K5 and K14 during epidermal development
(Byrne et al., 1994; Chazaud et al., 1996) and they have been
specifically implicated in the regulation of K5 and K14
expression (Kaufman et al., 2002; Leask et al., 1991; Luo et
al., 2002; Sinha and Fuchs, 2001; Sinha et al., 2000). Therefore,
we hypothesized that one or more AP-2 genes could be regulated
by TAp63a and that this accounts in part for the ability of
TAp63a to initiate an epithelial stratification program. Our gene
expression profiling studies demonstrated that the expression
levels of AP-2a, AP-2h, and AP-2gwere decreased by 5.9-fold,
4.2-fold, and 15-fold respectively in p63/ skin when
compared to wild type skin. Since RNA for gene expression
profiling was extracted from whole skin, which includes the
dermal compartment, we could not determine whether these
changes in gene expression reflected changes in the dermis, the
epidermis, or both. To determine which AP-2 gene could be
regulated by TAp63a, we performed RT-PCR analysis for AP-
2a, AP-2h, and AP-2g on RNA isolated from primary surface
epithelial cells obtained from E18.5 p63/ and wild type
embryos. We found that only AP-2g expression was absent from
p63/ surface epithelial cells, while AP-2a and AP-2h were
expressed (Fig. 1A). We confirmed these expression data by
performing Real-time RT-PCR which demonstrated that, similar
to the RT-PCR data, only AP-2g was not expressed in p63/
surface epithelial cells (Fig. 1B). Interestingly, we also noticed
that AP-2h expression was expressed at higher levels in p63/
epithelial cells when compared to wild type keratinocytes. While
AP-2h expression could be induced in an attempt to compensate
for AP-2g loss, AP-2h is unlikely to be able to fully compensate
for loss of AP-2g since p63/ epithelial cells do not express
K14. Taken together, our finding that p63/ surface epithelial
cells do not express AP-2g suggests that TAp63a may induce
AP-2g expression and that AP-2g may be involved in the
commitment to stratification.
To determine if TAp63a can induce AP-2g expression in
vivo, we used our previously generated gene-switch TAp63a
mice (Koster et al., 2004). By placing the regulator (Glp65) of
the gene-switch system under the control of a tissue-specific
promoter, transgene expression in this bigenic system can be
induced in a tissue-specific manner by administration of the
progesterone antagonist RU486 (Cao et al., 2002; Wang et al.,
1997, 1999). We previously used the K14 promoter to target
the expression of the regulator protein to the basal layer of the
epidermis (K14.Glp65) (Koster et al., 2004). These mice were
mated to mice carrying the inducible TAp63a transgene. In the
resulting bigenic mice, TAp63a expression could be induced
by administration of RU486. To determine if TAp63a could
induce AP-2g expression in the epidermis, we isolated primary
keratinocytes from gene-switch TAp63a and control newborn
mice. The primary keratinocytes were cultured under low Ca2+
conditions to maintain the cells in a proliferative, basal state.
TAp63a transgene expression was induced by supplementing
the growth media with 100 nM RU486 12 h prior to harvesting
the cells for Real-time RT-PCR analysis. As shown in Fig. 1C,
we found that expression levels of AP-2g, but not AP-2a or AP-2h, were increased 12 h after induction of TAp63a. Moreover,
AP-2g levels were further increased when TAp63a expression
was induced in p63+/ keratinocytes (K14.Glp65/TAp63a/
p63+/; Fig. 1C). In p63+/ skin, DNp63 expression levels are
reduced by ¨2-fold (data not shown), therefore, these data
suggest that DNp63a can inhibit AP-2g expression or prevent
the induction of AP-2g by TAp63a. As described in more detail
below, luciferase reporter gene assays confirmed that DNp63a
has a dominant-negative effect towards TAp63a on the
regulation of AP-2g expression (Fig. 2C).
At the time that the surface ectoderm commits to initiate a
stratification program, around E8.5, DNp63 isoforms are not
expressed (Koster et al., 2004). Therefore, competition between
TA- and DNp63 isoforms does not take place at this
developmental stage, suggesting that TAp63a could induce
AP-2g expression at higher levels in the single-layered surface
M.I. Koster et al. / Developmental Biology 289 (2006) 253–261256ectoderm than in primary keratinocytes. To determine if
TAp63a could induce AP-2g expression in single-layered
epithelia in vivo, we ectopically expressed TAp63a in single-
layered lung epithelia using our previously established lung
gene-switch TAp63a mice (SP-C.Glp65/TAp63a; (Koster et
al., 2004)). In these mice, the regulator protein was placed
under control of the surfactant protein C (SP-C) promoter
which targets transgene expression to type II alveolar cells and
distal Clara cells (Wikenheiser and Whitsett, 1997). After 7
days of daily RU486 injections, AP-2g expression levels in
lung biopsies taken from lung gene-switch TAp63a mice were
more than 10-fold higher than in control littermates (Fig. 1D).
In contrast, AP-2a and AP-2h expression levels remained
unchanged (Fig. 1D). Taken together, these data demonstrate
that TAp63a can induce AP-2g expression in single-layered
epithelia, such as the surface ectoderm.
In order to determine if TAp63a induces AP-2g expression
by directly binding to the AP-2g promoter, we initially
performed in vitro experiments to narrow down the region of
the AP-2g promoter that could be regulated by TAp63a. Cross-
species comparisons between human and mouse sequences
have been demonstrated to provide a reliable method to
identify regulatory elements (Wasserman et al., 2000). There-
fore, we performed an alignment of the mouse and human AP-
2g promoter sequences using the VISTA genome server (Fig.
2A) (Mayor et al., 2000). In the 2 kb region 5V to the AP-2g
transcription start site, three conserved regions were identified,
designated ‘‘AP-2g conserved 1’’ (1145 to 884), ‘‘AP-2g
conserved 2’’ (575 to 254), and ‘‘AP-2g conserved 3’’Fig. 3. TAp63a interacts with the AP-2g promoter in the surface ectoderm at E8.5. T
complete degenerate p53 binding site and one half-site (parameters: 0.70 matrix sim
determine if TAp63a can interact with these elements in the surface ectoderm, we i
antibody confirmed that we had isolated surface ectoderm (B). Propidium Iodide (P
performed on chromatin isolated from E8.5 surface ectodermal cells using an anti-
primers surrounding the ‘‘AP-2g conserved 1’’ region demonstrated an increased
immunoprecipitated with the p63a antibody (C). To determine which p63 iso
immunoprecipitation with the p63a antibody. For the subsequent Western blot ana
antibody reacts with both TAp63a and DNp63a (D; right). In the immunoprecipit
Taken together with our ChIP data, these data indicate that TAp63a is bound to t
stratification program.(234 to 1) (Fig. 2A). To determine if any of these conserved
regions could be regulated by TAp63a, we generated promoter
constructs in which a luciferase reporter gene was placed under
the control of these elements. In addition, we generated a
reporter construct containing a non-conserved region (1746
to 1377) to serve as a negative control. The four fragments
that we selected to test are indicated in Fig. 2A. Since TAp63a
functions in the single-layered surface ectoderm in vivo and
since TAp63a can induce K14 expression in cell lines derived
from single-layered epithelia in vitro (Koster et al., 2004), we
performed reporter gene assays in Ptk2 cells. Ptk2 cells are
derived from single-layered kidney epithelium and do not
express p63, AP-2g, or K14. Using transient transactivation
assays, we found that only ‘‘AP-2g conserved 1’’ could be
regulated by TAp63a (Fig. 2B). In addition, since our previous
studies suggested that DNp63a could have a dominant-
negative effect on AP-2g transactivation by TAp63a(Figs.
1C–D), we determined the ability of TAp63a to induce AP-2g
reporter gene expression in the presence of increasing amounts
of DNp63a. Unlike TAp63a, DNp63a could not induce AP-2g
expression (Fig. 2C). Furthermore, DNp63a prevented induc-
tion of AP-2g reporter gene expression by TAp63a (Fig. 2C),
demonstrating that DNp63a has a dominant-negative function
towards TAp63a in this context. Taken together, these data
demonstrate that TAp63a, but not DNp63a, can regulate an
element in the AP-2g promoter resulting in the induction of
AP-2g expression.
Since p63 is believed to transactivate gene expression by
binding to degenerate p53 response elements (Bian and Sun,he ‘‘AP-2g conserved 1’’ fragment of the mouse AP-2g promoter contains one
ilarity, 0.75 core similarity). Non-conserved basepairs are underlined (A). To
solated surface ectoderms from E8.5 embryos. Immunofluorescence with a p63
I) was used as a counterstain (B). Chromatin immunoprecipitation (ChIP) was
p63a antibody and a control anti-K14 antibody. Real-time PCR analysis using
recovery of promoter fragments containing ‘‘AP-2g conserved 1’’ in samples
forms were immunoprecipitated from the E8.5 embryos, we performed an
lysis, an antibody that recognizes all p63 isoforms (mAb4A4) was used. This
ates of E8.5 embryos, only TAp63a, and not DNp63a, was detected (D; left).
he AP-2g promoter at E8.5, when the surface ectoderm commits to initiate a
M.I. Koster et al. / Developmental Biology 289 (2006) 253–261 2571997; Zeng et al., 1998), we searched for degenerate p53
response elements within the AP-2g promoter using rVISTA
on the VISTA genome server. Using this analysis, we found
that the ‘‘AP-2g conserved 1’’ promoter region contains one
complete degenerate p53 response element (p53RE2) and one
half-site (p53RE1; Fig. 3A). Therefore, we hypothesized that
TAp63a directly interacts with this region in the surface
ectoderm when commitment to stratification occurs, around
E8.5. In order to address this hypothesis, we modified the
method for trypsin-based separation of germ layers described
by Levak-Svajger et al. (1969) to isolate surface ectoderms
from E8.5 embryos. To confirm that we had isolated the surface
ectoderm, we dissociated the cells and allowed them to attach
to a tissue culture dish. Immunofluorescence using a p63
antibody (mAb4A4; Yang et al., 1998) confirmed that the
majority of the cells isolated using this method expressed p63
(Fig. 3B). At this developmental stage, only the surface
ectoderm expresses p63 (Koster et al., 2004), therefore, these
data demonstrate the feasibility of isolating surface ectodermal
cells from E8.5 mouse embryos. To determine if TAp63a is
bound to the AP-2g promoter when commitment to stratifica-
tion occurs, we isolated ¨100 surface ectoderms from E8.5
embryos and performed chromatin immunoprecipitation (ChIP)
with an antibody that reacts with the a C-terminus of p63
(H129; Santa Cruz) and a control antibody. Real-time PCRFig. 4. Induction of K14 by TAp63a is dependent on AP-2g. To determine if AP-2
construct encoding AP-2g, or an empty vector. Immunofluorescence analysis using a
AP-2g could induce K14 expression (A). K14 expression was induced in ¨40% of
K14 (A). To determine if AP-2g expression is required for the induction of K14 by
subsequently with TAp63a. Transfection with AP-2g siRNA greatly reduced the ex
RNA expression level of K14 was reduced (C) and K14 protein expression was c
dependent on AP-2g.using primers surrounding the ‘‘AP-2g conserved 1’’ region
was used to determine if p63 was associated with the AP-2g
promoter. Using a standard curve generated with known
dilutions of input chromatin, we determined that the ‘‘AP-2g
conserved 1’’ fragment was present at ¨6-fold higher levels in
samples immunoprecipitated with the p63a antibody versus
samples immunoprecipitated with the control antibody (Fig.
3C). At E8.5, only TAp63 isoforms are expressed, therefore,
immunoprecipitation with a p63a antibody at this stage should
only result in recovery of TAp63a. To confirm that the
antibody was specific for p63a isoforms and to confirm that
only TAp63a was immunoprecipitated, we performed an
immunoprecipitation on E8.5 embryos using the same p63a
antibody. Subsequent Western blot analysis was performed
with a p63 antibody that reacts with all p63 isoforms
(mAb4A4). As shown in Fig. 3D, the p63a antibody only
immunoprecipitated TAp63a at E8.5, and no other p63
isoforms were recovered. Taken together, these data demon-
strate that TAp63a is bound to the AP-2g promoter in E8.5
surface ectoderm, resulting in the induction of AP-2g
expression.
Recently, using transient transactivation assays, an attempt
has been made to distinguish between p53 and p63 response
elements (Osada et al., 2005b). Based on these experiments, the
degenerate p53RE in the AP-2g promoter would be predictedg could induce K14 expression, Ptk2 cells were transfected with an expression
ntibodies against AP-2g (green) and K14 (red) demonstrated that, like TAp63a,
transfected cells. None of the cells transfected with the empty vector expressed
TAp63a, HR9 cells were transfected with AP-2g siRNA or control siRNA and
pression level of AP-2g at the RNA (B) and protein (E) levels. Moreover, the
ompletely absent (D), demonstrating that the induction of K14 by TAp63a is
Fig. 5. Schematic showing the role of TA- and DNp63 isoforms in epiderma
morphogenesis. During epidermal morphogenesis, different p63 isoforms
regulate distinct processes. While TAp63 isoforms are required for the
commitment to stratification, DNp63 isoforms regulate the commitment to
terminal differentiation (Koster et al., 2004). We now demonstrate that TAp63a
directly interacts with the AP-2g promoter at E8.5, when commitment to
stratification occurs. Furthermore, the resulting induction of AP-2g expression
is required for the subsequent expression of K14, which is first detected at E9.5
The molecular mechanism by which DNp63 isoforms regulate the commitmen
to terminal differentiation remains to be determined.
M.I. Koster et al. / Developmental Biology 289 (2006) 253–261258to be more highly activated by p63 than by p53. While these
findings are consistent with our data demonstrating that
TAp63a directly regulates AP-2g expression in vivo, the broad
in vivo implications of these in vitro reporter gene assays
remain to be determined.
To test if AP-2g could be the target gene of TAp63a
that is responsible for the induction of K14 expression, we
transfected Ptk2 cells with an AP-2g expression construct.
Immunofluorescence analysis demonstrated that, like
TAp63a (Koster et al., 2004), AP-2g was capable of
inducing K14 expression in these cells (Fig. 4A). In
addition, AP-2a and AP-2h could induce K14 expression,
albeit with lower efficiencies (data not shown). Taken
together with previous studies demonstrating that AP-2
directly binds to and activates the K14 promoter in mature
epidermis (Leask et al., 1991; Sinha et al., 2000), we
hypothesized that TAp63a induces K14 expression, a
marker for commitment to stratification, by directly regu-
lating AP-2g expression. To determine whether AP-2g
induction by TAp63a is required for the induction of
K14, we designed a siRNA to knock-down AP-2g
expression. The efficiency and specificity of target gene
expression knock-down were tested by transfecting HR9
cells with the AP-2g siRNA in conjunction with a TAp63a
expression construct (Fig. 4B). HR9 cells are derived from
mouse embryonic endoderm and do not express p63, AP-2g,
or K14. Since we had found that TAp63a can induce K14
expression in these cells (Koster et al., 2004), these cells
provided a suitable experimental system to study the genetic
interactions between TAp63a, AP-2g, and K14. The AP-2g
siRNA resulted in a >95% knock-down of AP-2g expres-
sion, while AP-2a and AP-2h expression levels were not
affected (Figs. 4B, E and data not shown). Therefore, we
determined if a reduction in AP-2g expression levels would
affect the ability of TAp63a to induce K14. As expected,
when we used a control siRNA construct, TAp63a could
induce K14 expression (Figs. 4C, D). However, transfection
of TAp63a in conjunction with AP-2g siRNA resulted in a
marked decrease in K14 mRNA levels, while it completely
blocked K14 protein expression (Figs. 4C, D). Taken
together, these data demonstrate that the induction of AP-
2g expression by TAp63a is required for the induction of
K14 expression.
AP-2g knockout mice die before epidermal morphogenesis
initiates due to developmental defects in extraembryonic
tissues (Auman et al., 2002; Werling and Schorle, 2002),
thereby preventing an analysis of the epidermal phenotype in
the absence of AP-2g. Furthermore, although embryonic
development appears to proceed normally in chimeras lacking
AP-2g expression in the embryo proper (Auman et al., 2002), a
detailed analysis of epidermal morphogenesis was not per-
formed. Since functional compensation by other AP-2 isoforms
may occur in the absence of AP-2g, confirmation of the critical
role for AP-2g in initiating K14 expression awaits a detailed
analysis of the epidermal phenotype of conditional AP-2g
knockout mice both before and after the commitment to
stratification takes place.Functional AP-2 binding sites have been identified in
both the mouse and human K14 promoters (Leask et al.,
1991; Sinha et al., 2000); however, the AP-2 isoform
involved in the regulation of K14 expression was not known
(Leask et al., 1991; Sinha et al., 2000). We now
demonstrate that, in the absence of AP-2g, TAp63a fails
to induce K14 expression in vitro, suggesting that AP-2g is
required for the initiation of K14 expression during
epidermal development (Fig. 5). Furthermore, since AP-2g
remains expressed in the basal layer of the epidermis
(Chazaud et al., 1996), these data suggest that AP-2g may
also be the AP-2 isoform required for the maintenance of
K14 expression in mature epidermis. The maintenance of
K14 expression in mature epidermis is believed to require
the cooperative function of several transcription factors,
including AP-1, AP-2, and ets (Sinha et al., 2000).
However, our data suggest that the induction of K14
expression during epidermal morphogenesis only requires
one transcription factor, AP-2g, and that other factors
required for the maintenance of K14 expression are recruited
to the K14 promoter between E9.5 and birth. Alternatively,
other transcription factors required for K14 expression could
already be present in the surface ectoderm prior to the
commitment to stratification, such that the induction of AP-
2g expression by TAp63a provides the final requirement for
induction of K14 expression. After the commitment to
stratification has occurred, a shift from TA- to DNp63
isoforms is required for terminal differentiation (Koster et
al., 2004) (Fig. 5). However, the molecular mechanism by
which DNp63 isoforms regulate the commitment to terminal
differentiation remains to be determined.
In summary, our data demonstrate that TAp63a directly
induces AP-2g expression in embryonic epidermis, when
commitment to stratification occurs. These data identify AP-l
.
t
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novel insights into the molecular mechanisms associated
with early events in epidermal morphogenesis.
Materials and methods
Primary keratinocyte culture
Primary keratinocytes were isolated and cultured as previously described
(Koster et al., 2004). Epithelial cells isolated from p63/ embryos were
harvested after 2 passages, and keratinocytes from K14.Glp65/TAp63a mice
and control littermates were harvested 12 h after supplementing the media with
100 nM RU486 to induce transgene expression.
Cell lines and transfections
Ptk2 cells (rat kangaroo kidney epithelial cells) and HR9 cells (mouse
embryonic endodermal cells) were cultured as described previously (Koster et
al., 2004). Ptk2 and HR9 cells do not express detectable amounts of p63, AP-
2g, or K14. Furthermore, while HR9 cells express AP-2h, AP-2a expression
could not be detected. Cells were transfected with expression constructs
encoding TAp63a (Yang et al., 1998), DNp63a (Yang et al., 1998), and AP-2g
(gift from Dr. Helen Hurst) using FuGene6 (Roche).
Reporter gene assays
A 2 kb fragment of the AP-2g promoter was cloned into pGL3-basic
(Promega). Conserved fragments within this 2 kb region were cloned into
pGL3-basic which was modified to include a minimal SV40 promoter derived
from the pGL3-control vector (Promega). Reporter constructs (500 ng) were co-
transfected with a TAp63a (500 ng) and/or DNp63a (100, 200, 500, 1000 ng)
expression construct (Yang et al., 1998) and a pCMV-hgal plasmid (50 ng).
Cells were harvested 48 h after transfection and luciferase assays were
performed using the dual-light\ combined reporter gene assay system for
detection of luciferase and h-galactosidase (Applied Biosystems). Average
reporter gene activities and standard deviations were determined based on three
independent experiments.
Immunofluorescence
Cells were fixed in cold methanol 48 h after transfection. Primary
antibodies used for immunofluorescence were rabbit-anti-AP-2g (Turner et
al., 1998), guinea pig anti-K14 (Koster et al., 2004), and mouse-anti-p63
(mAb4A4; (Yang et al., 1999)). Secondary antibody conjugates used were
Alexa-conjugated fluorochromes 488 goat-anti-rabbit, 594 goat anti-guinea pig,
and 488 goat anti-mouse (Molecular Probes). Images were acquired using a
Nikon Eclipse E600 microscope (Nikon Corporation). Objectives used were
Nikon Plan Apo 20x/0.75 (ectodermal cells) and Nikon Plan Fluor 40x/1.30 Oil
(transfected cells). Pictures were taken using a Photometrics Coolsnap fx
camera (Roper Scientific) and MetaVue imaging software (Universal Imaging
Corporation).
Real-time RT-PCR
Relative gene expression levels were determined by semi-quantitative Real-
time RT-PCR. RNA was isolated from lung biopsies taken from SP-C.Glp65/
TAp63a and control mice which were treated with 500 Ag/kg RU486 (Biomol)
for 5 days, from primary K14.Glp65/TAp63a and control keratinocytes 12
h after supplementing the media with 100 nM RU486, and from p63/ and
wild type surface epithelial cells using Trizol (Invitrogen). cDNA for Real-time
RT-PCR was prepared using the High-capacity cDNA Archive Kit (Applied
Biosystems). Assays-on-Demand TaqMan probes for AP-2a, AP-2h, and AP-
2g were obtained from Applied Biosystems. TaqMan Universal PCR Master
Mix (Applied Biosystems) was used for PCR amplification of the cDNA, and
Real-time RT-PCR reactions were performed in triplicate using the Opticon2
System (MJ Research). Each mRNAwas normalized to the level of 18S in eachsample and the relative amount of each gene was determined using the
comparative CT method.
Microarray analysis
RNA for microarray analysis was isolated from E18.5 p63/ and wild type
skin. RNA quality for microarray analysis was assessed with an Agilent 2100
Bioanalyzer. cRNA was synthesized using the Enzo Transcript Labeling Kit
(Affymetrix) and hybridized to the Affymetrix Mouse Genome U74v2 Set by
the Microarray Core of Baylor College of Medicine. Expression profiles were
analyzed using Microarray Analysis Suite 5.0 (Affymetrix), and GeneSpring
5.1 (Silicon Genetics). The microarray data have been deposited in NCBIs
Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are
accessible through GEO Series accession number GSE3108.
siRNA construction and transfection
Small interfering RNA (siRNA) sequences against AP-2g RNA were
selected using the siRNA target finder (Ambion). The Silencer siRNA
construction kit (Ambion) was used to generate siRNAs. The following siRNA
sequences were selected: AP2-g.AS 5V-AAG TCTAATACC CCATAT TTC-3V
and control.AS 5V-AAT GGG ATC TGT AAA TAC TTC-3V. For siRNA
transfection, HR9 cells were plated at a density of 5  104 cells per well of a
12-well plate and transfected with 10 nM siRNA the following day using
siPORT Amine (Ambion). The following day, the cells were transfected with
the TAp63a expression construct. Forty-eight hours after transfection, the cells
were harvested for RNA extraction, immunofluorescence analysis, or Western
blot analysis. Antibodies used for Western blot analysis were anti-AP-2g (H-77;
Sigma) and anti-TAp63 (mAb6E6; gift from Dr. Frank McKeon).
Isolation of embryonic surface ectodermal cells
Primary surface ectodermal cells were isolated using a method adapted
from Levak-Svajger et al. (1969). Timed pregnant ICR mice were obtained
from Harlan Sprague–Dawley and embryos were dissected at E8.5. Embryos
were cut in half and incubated in 0.5% trypsin for 1 h at room temperature.
After gently tapping the tubes, the surface ectoderm dissociated from the
embryo and was transferred to a separate tube.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed on surface ecto-
derms isolated from ¨100 E8.5 embryos. Surface ectodermal cells were fixed
in 1% formaldehyde for 15 min at RT and cross-linking was stopped by adding
a final concentration of 0.0125 M glycine. After washing the cells in solution I
(0.25% Triton, 10 mM EDTA, 1 mM EGTA, and 10 mM HEPES, pH 7.5), and
solution II (0.2 M NaCl, 1 mM EGTA, and 10 mM HEPES, pH 7.5), cells were
resuspended in lysis buffer (1% SDS and 10 mM EDTA) and sonicated.
Chromatin was immunoprecipitated with 3 Ag rabbit anti-p63a (H129; Santa
Cruz) or 3 Ag rabbit anti-K14 (Yuspa et al., 1989). Immunoprecipitated samples
were analyzed by semi-quantitative Real-time PCR as previously described
(Chakrabarti et al., 2002). Real-time PCR was performed using Quantitect
SYBR Green (Qiagen) with primers specific for the ‘‘AP-2g conserved 1’’
region (FW 5V-TTC TGC CTG GAA CCT CTT-3V and RV 5V-AAG CTG TAT
CTG GCT GCG-3V). The fold difference in promoter recovery between samples
immunoprecipitated with the p63a antibody and the K14 antibody was
determined based on a standard curve. A melting curve analysis was performed
for each sample to ensure that a single product of expected melting curve
characteristics was obtained.
Immunoprecipitation
Immunoprecipitation was performed on ¨30 E8.5 embryos with the Seize
Classic Mammalian Immunoprecipitation Kit (Pierce). Cell lysates were
incubated overnight with a p63a antibody (H-129; Santa Cruz) and immune
complexes were isolated the following day. Immunoprecipitated samples were
analyzed by Western blotting using the mAb4A4 antibody, which reacts with
M.I. Koster et al. / Developmental Biology 289 (2006) 253–261260all p63 isoforms (Yang et al., 1998). After incubation with an HRP-conjugated
anti-rabbit secondary antibody (Sigma), protein bands were visualized using
SuperSignal West Femto Maximum Sensitivity Substrate (Pierce).
All experiments involving mice were performed under IACUC approval
(Protocol number: AN-546).
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